Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2720)	5/7/2010 5:32:56 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

In spite of some good news yesterday, KOOL was down substantially today.<g> The stock opened with a DG and was down 11.45% on volume of > 778.12Ks >4x its ADV. bigcharts.marketwatch.com Yesterday it announced that it has signed a non-exclusive distribution agreement with GE Healthcare for its Res-Q60 BMC, a device used to prepare cell concentrates, including stem cells, from bone marrow. In January, KOOL signed an enhanced distribution agreement with GE Healthcare for its AXP System, used to process stem cells from cord blood, in a number of major regions throughout the world. Revenues have been lower in the last 2Qs, but if the EL for 2010is correct, the pending 4thQ results should be on the black, since the 9M loss is already $0.09 and the Yr. loss is estimated at $0.05 <g> The stock is trying to get off from the longer term DT coming from its Nov2006 H at $5.06 bigcharts.marketwatch.com Bernard